Med24
Clinical Medicine 9. 10. 2026 • 2 min read • medical-news

New Oral Drug Approved for Herpes Lesions

The FDA approved pritelivir (Hovilpri) tablets to treat mucocutaneous lesions caused by herpes simplex virus (HSV) infections in immunocompromised patients who haven't responded to other treatments. Pritelivir, an oral helicase...

New Oral Drug Approved for Herpes Lesions

The FDA approved pritelivir tablets for the treatment of mucocutaneous lesions resulting from herpes simplex virus (HSV) infections in immunocompromised patients who had not responded to other treatments. This oral drug, a helicase-primase inhibitor, targets both HSV-1 and HSV-2 strains resistant to nucleoside analogue and foscarnet-based therapies. HSV infections frequently cause lesions on the lips, nostrils, eyes, and genitals, especially in individuals with weakened immune systems. Rapid lesion healing and tolerability are crucial for these patients with treatment-resistant infections.

The approval followed results from the open-label phase III PRIOH-1 trial involving 101 immunocompromised patients with mucocutaneous HSV infection who had not responded to acyclovir, valacyclovir, or famciclovir. Participants had a variety of immunosuppressive conditions, including hematologic malignancies, stem-cell transplantation, HIV infection, autoimmune diseases, and organ transplantation.

Sponsored content

At 28 days, 63% of the patients taking 100 mg of pritelivir once daily achieved the primary efficacy endpoint of all lesions being healed. This compared to 34% of patients receiving foscarnet, cidofovir, or imiquimod as the investigators’ choice. The most commonly reported adverse reaction among patients treated with pritelivir was headache.

Original Scientific Source
medical-news
View Original Source
Medical Disclaimer All calculations, recommendations, and interpretations provided by this tool are for informational and educational purposes only. They do not substitute professional medical advice, diagnosis, or treatment. Always consult your physician regarding any health concerns.

Recommended Medical News

All news →
Advertisement